Karen Hübscher
Director/Board Member chez TECAN GROUP AG
Fortune : 360 229 $ au 31/03/2024
Postes actifs de Karen Hübscher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TECAN GROUP AG | Director/Board Member | 01/04/2012 | - |
| RUTILA RESOURCES LTD | Director/Board Member | - | - |
| SANDOZ GROUP AG | Director/Board Member | 01/08/2023 | - |
| Dispopharm D&P AG | Director/Board Member | - | - |
| FibulaMedical AG | Chief Executive Officer | 01/01/2012 | - |
| Founder | 01/01/2012 | - | |
| Schweizerische Management Gesellschaft | Director/Board Member | - | - |
| IMD Scholarship Foundation | Director/Board Member | - | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Director/Board Member | - | - |
Historique de carrière de Karen Hübscher
Anciens postes connus de Karen Hübscher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Novartis Vaccines & Diagnostics Services AG | Corporate Officer/Principal | 01/01/2006 | 01/01/2011 |
| ░░░░░░░░ ░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Karen Hübscher
| Swiss Federal Institute of Technology | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Statistiques
Internationale
| Suisse | 13 |
| Australie | 2 |
Opérationnelle
| Director/Board Member | 8 |
| Chief Executive Officer | 2 |
| Public Communications Contact | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Non-Energy Minerals | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| TECAN GROUP AG | Health Technology |
| SANDOZ GROUP AG | Health Technology |
| Entreprise privées | 8 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
| IMD Scholarship Foundation | |
| Schweizerische Management Gesellschaft | |
BBI Group Pty Ltd.
 BBI Group Pty Ltd. Other Metals/MineralsNon-Energy Minerals BBI Group Ltd. operates as a resource and energy exploration company. Its projects include include Balla Balla and Eucla West Mineral Sands. The company was founded on October 8, 2009 and is headquartered in Sydney, Australia. | Non-Energy Minerals |
| Dispopharm D&P AG | |
| FibulaMedical AG | |
| Novartis Vaccines & Diagnostics Services AG |
- Bourse
- Insiders
- Karen Hübscher
- Expérience
